The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending ...

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk, ...

The Food and Drug Administration is shifting its annual COVID-19 vaccine approval policies to focus on Americans older than ...

The FDA announces changes for who's eligible for the COVID-19 vaccine. Plus, should musicians shut up & sing or tell critics ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

Dr. Peter Chin Hong, a Bay Area infectious disease expert, discusses the stricter policy from the Food and Drug ...

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...

About a fourth of younger men surveyed in the United States feel lonely, which is significantly higher than the national ...